Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214350 · ClinicalTrials.gov registry record
Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation
A clinical trial of Heart Disease and Cardiac Rehabilitation, sponsored by Duke University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07214350: Recruiting study of Heart Disease and Cardiac Rehabilitation, sponsored by Duke University.
NCT07214350 is a study of Heart Disease and Cardiac Rehabilitation that is actively recruiting participants, run by Duke University. The registered enrollment target is 150 participants, below the 2,042-participant average among 31 other Heart Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214350, a study of Heart Disease and Cardiac Rehabilitation, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they complete cardiac rehabilitation. Participants in this study will have three in-person study visits and may complete two qualitative interviews over a 10-month study period. The greatest risks during the study include physical discomfort, falling, and/or shortness of breath during the fitness testing.
Primary Outcome
Calculated as an average of daily steps achieved over the previous week at each timepoint.
Conditions Studied
Study Locations (1)
North Carolina
- Duke Center for Living - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2030-08 |
What NCT07214350 shows while recruiting
NCT07214350 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,042-participant average among 31 other Heart Disease trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT07214350 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07214350 about?
NCT07214350 is a clinical study titled "Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation". The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during a...
What is the current status of trial NCT07214350?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-12-02. Estimated completion is 2030-08.
What conditions does trial NCT07214350 study?
This clinical trial studies the following conditions: Heart Disease, Cardiac Rehabilitation.
Who is sponsoring clinical trial NCT07214350?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07214350 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07214350's enrollment target sits among peer trials
150 21st of 31 higher than 10 of 31 other Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
-
Personalized Environment and Genes Study
RECRUITING
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
RECRUITING · NA
-
Heart Disease of the Small Arteries in Women and Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI